Edwards Lifesciences Corporation EW

86.29 0.56 0.65% as of 25 Sep
Market cap
$49.4B
P/E
49.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Edwards Lifesciences Corporation (EW) P/S ratio

As of 25 September 2026, Edwards Lifesciences Corporation (EW) trades at a P/S ratio of 7.6×. Over the past ten years it has ranged from 5.6× (May 2015) to 16.0× (December 2021); the current reading is higher than 23% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.8×.

P/S ratio, daily

Annual

Period P/S ratio Change
FY2025 8.2× 1.01%
FY2024 8.1× (11.11%)
FY2023 9.2× (11.14%)
FY2022 10.3× (33.27%)
FY2021 15.4× 19.17%
FY2020 12.9× 15.89%
FY2019 11.2× 29.81%
FY2018 8.6× 25.67%
FY2017 6.8× (0.23%)
FY2016 6.9× 0.57%

Quarterly

Period P/S ratio Change
Jun 2026 8.0× 8.81%
Mar 2026 7.4× (10.45%)
Dec 2025 8.2× 6.32%
Sep 2025 7.7× (4.30%)
42 more quarters

Against its own ten years

Low 5.6× High 16.0×
Ten-year median 8.7×
Current reading's percentile 23

P/S ratio against peers

Company P/S ratio
PHG Koninklijke Philips N.V. compare 1.2×
GEHC GE HealthCare Technologies Inc. compare 1.4×
ZBH Zimmer Biomet Holdings, Inc. compare 2.1×
MDT Medtronic PLC compare 3.0×
BSX Boston Scientific Corporation compare 3.1×
STE STERIS plc compare 3.4×
SYK Stryker Corporation compare 4.0×
DXCM DexCom, Inc. compare 6.7×
EW Edwards Lifesciences Corporation 7.6×
Medical Devices industry median 2.7×
Healthcare sector median 3.8×
Market median 2.0×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on EW